MustGrow Biologics Corp.
MGRO.V
TSX
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 70.60K | 621.40K | 573.00K | 2.06M | 2.64M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 70.60K | 621.40K | 573.00K | 2.06M | 2.64M |
| Cost of Revenue | 139.80K | 660.00K | 506.00K | 1.76M | 56.00K |
| Gross Profit | -69.20K | -38.60K | 66.90K | 301.60K | -56.00K |
| SG&A Expenses | 413.30K | 811.70K | 1.60M | 863.30K | 540.70K |
| Depreciation & Amortization | -- | 9.60K | 9.70K | 9.60K | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 642.10K | 1.56M | 2.23M | 2.69M | 681.90K |
| Operating Income | -571.50K | -943.00K | -1.65M | -630.10K | -681.90K |
| Income Before Tax | -626.60K | -1.51M | -1.76M | -787.00K | -952.30K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -626.60K | -1.51M | -1.76M | -787.00K | -952.30K |
| Earnings from Discontinued Operations | -324.50K | -- | -- | -- | -190.70K |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -951.20K | -1.51M | -1.76M | -787.00K | -1.14M |
| EBIT | -571.50K | -943.00K | -1.65M | -630.10K | -681.90K |
| EBITDA | -564.70K | -936.10K | -1.65M | -623.20K | -675.20K |
| EPS Basic | -0.02 | -0.03 | -0.03 | -0.02 | -0.02 |
| Normalized Basic EPS | -0.01 | -0.01 | -0.02 | -0.01 | -0.01 |
| EPS Diluted | -0.02 | -0.03 | -0.03 | -0.02 | -0.02 |
| Normalized Diluted EPS | -0.01 | -0.01 | -0.02 | -0.01 | -0.01 |
| Average Basic Shares Outstanding | 61.93M | 58.90M | 54.71M | 52.13M | 51.58M |
| Average Diluted Shares Outstanding | 61.93M | 58.90M | 54.71M | 52.13M | 51.58M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |